Skip to content

BTS 2015 Pulmonary Nodule Guideline Navigator

BTS 2015 (Callister, Thorax)

Walks a pulmonary nodule through the British Thoracic Society 2015 pathway by type (solid, pure ground-glass, part-solid), size/volume, persistence and Brock/Herder risk, returning the guideline-recommended next step — discharge, surveillance CT with interval, PET-CT, biopsy or resection.

Also searched as: lung nodule · ground-glass · part-solid · surveillance · decision tree · follow-up · lung

Nodule type
Maximum diameter

Provide diameter and/or volume; BTS thresholds pair <5 mm with <80 mm³ and ≥8 mm with ≥300 mm³.

mm
Nodule volume (optional)

From volumetry software; used if diameter is not provided (the higher class governs if both given).

mm³
Scan timing (subsolid nodules)

Required for ground-glass/part-solid nodules ≥5 mm; ignored for solid nodules.

Brock malignancy risk (optional)

Required for solid nodules ≥8 mm/≥300 mm³ and persistent subsolid nodules ≥5 mm — compute with the brock-spn calculator.

%
Herder post-PET risk (optional)

Only after PET-CT when Brock risk ≥10% — compute with the herder-spn calculator.

%
Growth signal (subsolid nodules)

Escalates persistent subsolid nodules toward treatment per BTS.

Information
Incomplete input
  • Please provide: nodule type (solid / pure ground-glass / part-solid), nodule maximum diameter (mm) or volume (mm³).

How this tool works

The BTS 2015 guideline (Callister, Thorax, NICE-accredited) departs from Fleischner by removing smoking-history stratification for small nodules and by driving larger-nodule management with two validated prediction models. Solid nodules below 5 mm (or 80 mm³) are discharged; 5 to <8 mm (or 80–<300 mm³) enter CT surveillance with volumetric doubling-time assessment (3-month and 1-year CT for nodules ≥6 mm or ≥80 mm³; 1-year CT for 5–<6 mm; discharge if stable at 1 year, or after 2 years of 2D follow-up). Solid nodules ≥8 mm (or ≥300 mm³) are assessed with the Brock model: below 10% go to surveillance, at or above 10% to PET-CT with Herder re-assessment, then surveillance (<10%), consideration of image-guided biopsy (10–70%), or surgical resection (>70%). Subsolid nodules below 5 mm need no follow-up; larger ones are re-scanned with thin-section CT at 3 months, and persistent ones are Brock-stratified to CT at 1, 2 and 4 years (~<10%) or a discussion of observation, biopsy and treatment (~>10%). Ground-glass nodules enlarging by ≥2 mm, and part-solid nodules with a growing or new solid component, are escalated toward resection or non-surgical treatment.

Clinical questions that use this

Vetting guides that reach for this tool.